Vanguard Group Inc Procept Bio Robotics Corp Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
A detailed history of Vanguard Group Inc transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Vanguard Group Inc holds 5,248,072 shares of PRCT stock, worth $203 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,248,072
Previous 5,127,137
2.36%
Holding current value
$203 Million
Previous $299 Million
1.2%
% of portfolio
0.01%
Previous 0.01%
Shares
16 transactions
Others Institutions Holding PRCT
# of Institutions
291Shares Held
44MCall Options Held
236KPut Options Held
91.9K-
Black Rock Inc. New York, NY3.49MShares$135 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY2.16MShares$83.3 Million0.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.53MShares$59 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.32MShares$51 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.3MShares$50.1 Million0.01% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $1.72B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...